New Trial Ordered for Premature Infant Formula Lawsuit Over NEC Injuries, After Defense Verdict Overturned
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Children May Be Given Unnecessary Antibiotics to Prevent Early Onset Neonatal Sepsis: Study While early onset sepsis can be fatal, doctors may be contributing to antibiotic overuse and the evolution of resistant superbugs by giving it to children at low or no risk. January 18, 2022 Martha Garcia Add Your Comments Despite global concerns about the long-term effects of antibiotic overuse, the findings of a new study suggests that infants are often prescribed the drugs even when there is little to no risk of developing early onset sepsis. Early onset neonatal sepsis is a complex illness impacting infants, which occurs after exposure to bacteria during birth. The infections can evolve rapidly in the first 72 hours after birth and can be fatal, even after antibiotics have been administered. In a report published this month in the medical journal Pediatrics, researchers with the Children’s Hospital of Philadelphia Newborn Care report that more than 80% of newborns at low risk for developing early onset sepsis and 91% of infants considered to have no risk were given antibiotics to combat the infections, resulting in unnecessary use of the medications. Overuse of antibiotics has become a serious concern in the medical community, potentially leading to the development of “superbug” infections that are resistant to available medications and difficult to treat. Prior research has found that low-birth-weight infants considered at low risk for early onset sepsis can be given antibiotics without serious risks, leading many doctors tending to err on the side of caution and give infants antibiotics after birth. However, in this latest study, researchers warn that a substantial proportion of this antibiotics administered are unnecessary, urging doctors to exercise more caution in deciding whether to use the drugs. BABY FORMULA NEC LAWSUITS Was your premature child fed Similac or Enfamil? Premature infants fed Similac or Enfamil cow’s milk formula face an increased risk of necrotizing enterocolitis (NEC) or wrongful death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION BABY FORMULA NEC LAWSUITS Was your premature child fed Similac or Enfamil? Premature infants fed Similac or Enfamil cow’s milk formula face an increased risk of necrotizing enterocolitis (NEC) or wrongful death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The study focused on infants born 2009 to 2014, with blood cultures with or without cerebrospinal fluid culture obtained more than 72 hours after birth. Low early onset sepsis risk was determined if mothers had a cesarean delivery, their water did not break before delivery, or there was no concern regarding intra-amniotic infection. Nearly 54,000 births were included in the study, but only 7,549 infants were evaluated. Of the infants evaluated, 0.5% had early onset sepsis. This translates to only 41 infants developing early onset sepsis out of the 7,500 infants assessed. However, low-risk delivery characteristics were present for about 15% of the infants overall, or about 1,100 newborns, but none of them had early onset sepsis. Among the newborns, doctors administered antibiotics to 80% of infants born with low-risk characteristics and 91% of infants born without low-risk characteristics. In both groups, despite the presence or lack of characteristics, doctors administered antibiotics to a majority of infants. The duration antibiotics were administered to infants born with and without low-risk characteristics did not differ. Doctors largely did not distinguish between low-risk infants and infants with no risk when giving antibiotics. Applying risk assessments to newborns may help to reduce courses of antibiotics given to infants, the researchers concluded. Offering antibiotics only to infants with risk assessment of early onset sepsis and not to those that don’t meet the criteria could reduce how frequently newborns are taking antibiotics. “Risk of early onset sepsis among infants with low-risk delivery characteristics is extremely low,” wrote study authors. “Despite this, a substantial proportion of these infants are administered antibiotics. Delivery characteristics should inform empirical antibiotic management decisions among infants born at all gestational ages.” Health experts say the unnecessary use of the medications contributes to the proliferation of antibiotic resistant bacteria. Previous research has warned that antibiotic-resistant bacteria could kill more than 10 million people every year by 2050 if measures are not implemented to reduce unnecessary prescribing. Tags: Antibiotic Resistance, Antibiotics, Infant, Infection, Sepsis Find Out If You Qualify for Infant Formula NEC Compensation More Baby Formula Lawsuit Stories New Trial Ordered for Premature Infant Formula Lawsuit Over NEC Injuries, After Defense Verdict Overturned March 18, 2025 Infant Formula Lawsuit Links Similac and Similac Special Care to Newborn’s NEC Injuries January 27, 2025 NEC Injury Lawyers Reappointed to Leadership Roles in Baby Formula MDL as Bellwether Trials Loom January 17, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (Posted: today) As new BioZorb lawsuits continue to be filed over complications with the recalled breast tissue markers, lawyers indicate they are on track for the first of four test cases to go before a jury in September 2025. MORE ABOUT: BIOZORB LAWSUITCourt Clears BioZorb Lawsuit Design Defect Claims Over Recalled Breast Tissue Marker (03/26/2025)Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker (03/19/2025)Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (03/12/2025) Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (Posted: yesterday) Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (03/24/2025)Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025) Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (Posted: 2 days ago) An Indiana woman has filed a Cartiva SCI implant lawsuit, indicating that the toe implant failed due to a defective design, resulting in the need for revision surgery and recommendations to permanently fuse her big toe. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Implant Injury Lawsuit Set for Trial in February 2026 (03/07/2025)Lawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025)
New Trial Ordered for Premature Infant Formula Lawsuit Over NEC Injuries, After Defense Verdict Overturned March 18, 2025
Infant Formula Lawsuit Links Similac and Similac Special Care to Newborn’s NEC Injuries January 27, 2025
NEC Injury Lawyers Reappointed to Leadership Roles in Baby Formula MDL as Bellwether Trials Loom January 17, 2025
Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (Posted: today) As new BioZorb lawsuits continue to be filed over complications with the recalled breast tissue markers, lawyers indicate they are on track for the first of four test cases to go before a jury in September 2025. MORE ABOUT: BIOZORB LAWSUITCourt Clears BioZorb Lawsuit Design Defect Claims Over Recalled Breast Tissue Marker (03/26/2025)Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker (03/19/2025)Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (03/12/2025)
Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (Posted: yesterday) Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (03/24/2025)Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025)
Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (Posted: 2 days ago) An Indiana woman has filed a Cartiva SCI implant lawsuit, indicating that the toe implant failed due to a defective design, resulting in the need for revision surgery and recommendations to permanently fuse her big toe. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Implant Injury Lawsuit Set for Trial in February 2026 (03/07/2025)Lawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025)